Keywords
Facial Paralysis
Bruxism
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: This study aims to analyze the therapeutic potential of botulinum toxin in the treatment of facial paralysis and bruxism. Methods: Following the PRISMA guidelines, an integrative literature review was conducted, adopting a reflective approach to the subject. The PubMed MEDLINE and Virtual Health Library (BVS) databases were used for article retrieval, employing the descriptors "botulinum toxin" combined with "bruxism" and "facial paralysis". Results: A total of 20 articles were included and grouped into three themes: "efficacy of botulinum toxin in the treatment of facial paralysis", "innovation in facial paralysis treatment with botulinum toxin", and "efficacy of botulinum toxin in the treatment of bruxism". The study included 2143 patients, demonstrating that this therapeutic approach can be indicated for the treatment of bruxism and facial paralysis. Final Considerations: The application of botulinum toxin proved to be effective in the treatment of facial paralysis and bruxism, with no need for additional adjunctive therapy in combination.
References
AFCHAIN F, et al. Estabilização e reanimação do lábio inferior na paralisia facial. Estudo retrospectivo de 66 pacientes e revisão da literatura. Proposição de um algoritmo de decisão. An de Chirur., 2022; 67: 20-25.
ALI SM, et al. Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trial. Saudi Dent J, 2021; 33: 1004-1011.
BARBOSA CMR e BARBOSA JRA. Toxina botulínica em odontologia. 1 Ed. Rio de Janeiro: Elsevier Ltda, 2017.
CAHLIN BJ, et al. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial. Clin Exp Dent Res,2019; 5: 460-468.
CAZUMBÁ F DE B, et al. Uso de Toxina Botulínica em Odontologia. Revista Fluminense de Odontologia, 2017; 47.
CFO. RESOLUÇÃO CFO-176, de 06 de setembro de 2016, 2016.
CRUSE B, et al. Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double- blind, randomised, placebo-controlled, cross-over study. BMJ Neurol Open, 2022; 4: e000328.
DA SILVA RAMALHO JA, et al. Effect of botulinum toxin A on pain, bite force, and satisfaction of patients with bruxism: A randomized single-blind clinical trial comparing two protocols. Saudi Dent J, 2023; 35: 53- 60.
DE CARVALHO VF, et al. Avaliação da imagem corporal de pacientes com paralisia facial antes e após a aplicação da toxina botulínica. Int J Dermatol, 2019; 58.
DE LIMA MC, et al. Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder?. Cranio, 2021; 1-8.
DE MAIO M e RZANY B. Botulinum Toxin in Aesthetic Medicine. 1 Ed. Berlin Heidelberg: Springer-Verlag, 2007.
DIRACOGLU D, et al. Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy. Turk J Phys Med Rehabil, 2021; 67: 351-356.
ERDIL D, et al. The Evaluation of the Relationship between Changes in Masseter Muscle Thickness and Tooth Clenching Habits of Bruxism Patients Treated with Botulinum Toxin A. J Med Ultrasound, 2022; 31: 22-28.
GOUVEIA BN, et al. O uso da toxina botulínica em procedimentos estéticos. R Brasileira Militar de Ciências, 2020; 6.
HEFTER H e SAMADZADEH S. The Necessity of a Locally Active Antidote in the Clinical Practice of Botulinum Neurotoxin Therapy: Short Communication. Medicina (Kaunas), 2022; 58: 935.
HOSGOR H, et al. Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism. J Korean Assoc Oral Maxillofac Surg, 2020; 46: 335-340.
JUNG BK, et al. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study. J Craniomaxillofac Surg, 2023; 51: 332-337.
KANERVA M. Sincinesia bucinadora tratada com toxina botulínica em paralisia facial e espasmos hemifaciais. JPRAS, 2021; 74: 1464-1469.
KATO Y, et al. Quantitative evaluation of oral function in acute and recovery phase of idiopathic facial palsy; a preliminary controlled study. Clin Otolaryngol, 2013; 38: 231-236.
LACROIX G, et al. O músculo bucinador: um novo dispositivo para injeções de toxina botulínica no tratamento de sequelas de paralisia facial. Annales de Chirurgie Plastique Esthétique, 2022; 67: 125-132.
MORALEDA S, et al. Encuesta de satisfacción del paciente con secuelas de parálisis facial periférica en tratamiento con toxina botulínica A. Rehabilitación, 2020; 54: 254-259.
MOHER D, et al. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA Statement. Opne Medicine, 2009; 2(3): 123–130.
PARDO NB, et al. Botulinum toxin type A for controlling bruxism assessed with computerized occlusal analysis: A pilot study. Cranio, 2022; 40: 207-216.
SERRERA-FIGALLO MA, et al. Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins (Basel), 2020; 12: 112.
SHEHRI, ZG, et al. Evaluation of the Efficacy of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle for the Treatment of Nocturnal Bruxism: A Randomized Controlled Clinical Trial. Cureus, 2022; 14: e32180.
SHIM YJ, et al. Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo- Controlled Trial. Toxins (Basel), 2020; 12: 168.
STEINHÄUSER J, et al. Cuidados Multidisciplinares de Pacientes com Paralisia Facial: Tratamento de 1220 Pacientes em um Centro de Nervo Facial Alemão. Revista de Medicina Clínica, 2022; 11: 427.
THIEN Chan I, et al. Toxina botulínica no tratamento de sequelas da paralisia facial: área de atuação do dermatologista. Surg Cosmet Dermatol, 2019; 11: 238-243.
WENCESLAU LGC, et al. Paralisia facial periférica: atividade muscular em diferentes momentos da doença. CoDAS, 2016; 28: 3-9.
YURTTUTAN ME, et al. Which Treatment Is Effective for Bruxism: Occlusal Splints or Botulinum Toxin?. J Oral Maxillofac Surg, 2019; 77: 2431-2438.